Radnostix closes Lucerno asset acquisition for LARA and ELLEXA platforms

The deal adds patient-safety and dosimetry tools for radiopharmaceutical administration as Radnostix expands its theranostics delivery and monitoring portfolio.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.